Why Tessera Believes Its Gene Writing Platform Can Go Way Beyond CRISPR

Interview: Bio-Entrepreneur On The Hunt For The Definitive Genetic Medicine Platform

As the first CRISPR-based therapies draw closer to approval, the Flagship-backed biotech believes its gene writing tech is the ‘definitive’ genetic medicine platform.

Single strand ribonucleic acid, RNA
The company was established four years ago, and will soon be ready to share its initial data with the world. • Source: Shutterstock

More from Gene Therapies

More from Advanced Therapies